The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...

Pregnancy and breastfeeding induces the accumulation of specialized immune cells that reduce the chances of breast cancer ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...

Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...

Apple has an official fix for users who can't activate iMessage after updating to iOS 26. The issue has to do with an inactive SIM or eSIM following the update. Removing or deleting the inactive SIM ...

Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment. Trial investigator Emma Guttman, MD, PhD, chair of ...

Attorney General Ken Paxton says his office is running undercover investigations targeting what he calls "leftist terror cells" in Texas. Russia issues Afghanistan ...